中华临床医师杂志(电子版)2023,Vol.17Issue(10) :1117-1122.DOI:10.3877/cma.j.issn.1674-0785.2023.10.016

miR-107与恶性肿瘤的研究进展

Progress in understanding of relationship between microRNA-107 and malignant tumors

贺彬 刘迅 胡东辉
中华临床医师杂志(电子版)2023,Vol.17Issue(10) :1117-1122.DOI:10.3877/cma.j.issn.1674-0785.2023.10.016

miR-107与恶性肿瘤的研究进展

Progress in understanding of relationship between microRNA-107 and malignant tumors

贺彬 1刘迅 1胡东辉1
扫码查看

作者信息

  • 1. 430033 武汉,湖北省第三人民医院中医科
  • 折叠

摘要

microRNA-107(miR-107)是具有多种疾病中起调节作用的miRNAs,在肿瘤细胞的生长、分化、增殖、发育、凋亡和代谢等多种过程中发挥重要作用,与多种肿瘤有关。在恶性肿瘤的发生发展中,有时作为癌基因促进恶性肿瘤的进展,有时又作为抑癌基因对恶性肿瘤起到抑制作用。总之,miR-107极有可能成为恶性肿瘤的诊断和治疗中新的生物标志物。本文对miR-107在不同系统恶性肿瘤中的作用及其可能机制进行具体阐述,并对其今后的研究方向提出自己的见解,旨在为miR-107在恶性肿瘤的诊治方面起到一定的推动作用。

Abstract

MicroRNA-107 (miR-107) is a microRNA that plays a regulatory role in various diseases. It plays an important role in various processes such as tumor cell growth, differentiation, proliferation, development, apoptosis, and metabolism, and is associated with various tumors. In the occurrence and development of malignant tumors, miR-107 may act as an oncogene to promote the progression of malignant tumors, and it can also act as a tumor suppressor gene to suppress malignant tumors. Thus, miR-107 is highly likely to become a new biomarker in the diagnosis and treatment of malignant tumors. This article provides a detailed explanation of the role and possible mechanisms of miR-107 in malignant tumors of different systems, and proposes our own insights into the future research directions, aiming to promote the diagnosis and treatment of malignant tumors.

关键词

miR-107/恶性肿瘤/癌基因/抑癌基因

引用本文复制引用

基金项目

湖北省中医药管理局2023-2024年度项目(ZY2023F032)

出版年

2023
中华临床医师杂志(电子版)
中华医学会

中华临床医师杂志(电子版)

CSTPCD
影响因子:0.99
ISSN:1674-0785
参考文献量25
段落导航相关论文